{
Sangamo Therapeutics, Inc.

Companies

}
Symbol SGMO
Name Sangamo Therapeutics, Inc.
Currency USD
Sector Health Care
IndustryGroup Pharmaceuticals, Biotechnology & Life Sciences
Industry Biotechnology
Market NASDAQ Global Select
Country United States
State CA
City Brisbane
Zipcode 94005
Website http://www.sangamo.com
Track all markets on TradingView
sangamo shares soar after roche halts hemophilia a gene therapy program
Sangamo Therapeutics' shares surged by 36% following Roche's decision to discontinue its gene therapy program for hemophilia A, specifically the SPK-8011 therapy. This marks Sangamo's largest stock increase since October 28. The company is collaborating with Pfizer on a competing gene therapy, giroctocogene fitelparvovec, targeting the same condition.
Investing.com
Sangamo Therapeutics, Inc. Hoffmann-La Roche AG Pfizer Inc. USA Show more
Healthcare, Market Report
21:08 16.12.2024
sangamo shares rise sharply after roche halts hemophilia gene therapy program
Sangamo Therapeutics saw its shares soar by 36% after Roche announced the discontinuation of its gene therapy program for hemophilia A, specifically the SPK-8011 therapy. This decision, described as a "strategic decision," follows Roche's acquisition of Spark Therapeutics in 2019. Sangamo is collaborating with Pfizer on a competing gene therapy, giroctocogene fitelparvovec, targeting the same condition.
Investing.com Canada
Sangamo Therapeutics, Inc. Hoffmann-La Roche AG Pfizer Inc. USA Jean Rochefort Show more
Healthcare, Market Report
21:06 16.12.2024
ipr001 begins first human trial as global crispr market expands rapidly
SNIPR BIOME ApS has initiated the first human clinical trial for SNIPR001, targeting E. coli colonization in healthy volunteers, set to begin in the first half of 2022. The global CRISPR technology market is projected to grow significantly, with North America leading in market share, driven by advancements in biomedical applications and increasing research activities.
Spherical Insights
United States Dollar Integrated DNA Technologies Inc. Mirus Bio LLC Sangamo Therapeutics, Inc. CRISPR Therapeutics AG Genscript Abbott Laboratories Merck & Co., Inc. NEW England Biolabs Inc. Thermo Fisher Scientific Inc. Lonza Group AG Takara Bio Inc. ABio-Rad Laboratories Inc USA DEU MEX ITA ARG AUS ZAF IND RUS JPN KOR GBR BRA CAN ARE ESP CHN Show more
Healthcare, Market Report
20:26 28.10.2024
merck acquires cancer startup elevidys sales rise and other industry updates
Merck & Co. has acquired Modifi Biosciences for $30 million, with potential additional payments of up to $1.3 billion based on milestones. Meanwhile, Roche reported that sales of Sarepta's gene therapy Elevidys reached approximately $156 million outside the U.S. in the first nine months of the year. Sangamo Therapeutics is on track to file for accelerated approval of its Fabry disease treatment, while MacroGenics sold rights to its breast cancer drug Margenza for $40 million, with additional milestone payments possible.
BioPharma Dive
United States Dollar Swiss Franc Hoffmann-La Roche AG Merck & Co., Inc. UCB SA Sarepta Therapeutics, Inc. Sangamo Therapeutics, Inc. Ned Pagliarulo Delilah Alvarado Jonathan Gardner Alessandro Maselli Show more
Healthcare, Market Report
17:45 23.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Corporate Responsibility & ESG Market Sentiment Analysis Central Bank Actions Decentralized Finance (DeFi) Innovations Cryptocurrency & Blockchain Regulations Banking Regulations Tokenomics and Crypto Economics Cryptocurrency Regulations Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Funding Rounds & Investments Mergers & Acquisitions Cryptocurrency Developments SEC & Financial Compliance Inflation Rates & CPI Data Real Estate Investments Shareholder Activism
Countries:
USA CHE JPN AUS CAN IND GBR DEU AUT CHN HKG RUS LIE SAU BHR FRA ARG COL FIN NLD
Companies:
Coinbase Global, Inc. Ripples USD Solana USD BlackRock, Inc. Ethereum USD Credit Suisse Real Estate Fund Siat NVIDIA Corporation Cardano USD Tesla, Inc. Apple Inc. MicroStrategy Incorporated Amazon.com, Inc. Sumitomo Corp Google Inc. Bitwise Bitcoin ETF Chainlink USD Palantir Technologies Inc. Tether USDt CNY VAT Group AG Northern Star Resources Ltd
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Canadian Dollar Colombian Peso Singapore Dollar Indian Rupee
People:
Ali Martinez Donald Trump Michael J. Saylor Elon Musk Karin Keller-Sutter Charles Hoskinson Bill Gates Fred Thiel Jack Dorsey Jacob King Brian Armstrong Aaron Green Gary Gensler Ueli Maurer Mario Nawfal Alan Santana Richard Schueler Roger J. Hamilton Steven Rossi Jane Dietze

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.